In the present study, our data also showed that administration of DSF led to a substantial increase in the number of pulmonary CD68+ and CD86+ macrophages (M1 subtype) in experimental MA-ALI/ARDS mice. This evidence concerns the gene CD68 and acute respiratory distress syndrome.